Avalo Therapeutics GAAP EPS of -$0.83 in-line, revenue of $5.4M misses by $0.68M
March 02 2022 - 7:49AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Apr 2023 to Apr 2024